ATLANTICUS HOLDINGS CORPORATION Key Metrics

2 years of history · ending 2025-12-31 · SEC EDGAR

Per Share Metrics

Expense Ratios

Working Capital Analysis

Valuation Multiples

Cash-Flow Multiples

Enterprise Value Multiples

52-Week Range

Trailing Returns

Yields

Capital Deployment Yields

Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)

EPS (Diluted)
$6
Book Value Per Share
$32
Free Cash Flow Per Share
$33
Cash Per Share
$32
Revenue Per Share
$103
OCF Per Share
$33
Return on Equity
22.2%
Return on Assets
2.2%
Asset Turnover
0.36
SBC / Revenue
0.2%
Capex / Revenue
Invested Capital
$609M
OCF / Net Income
5.22
FCF / Net Income
5.22
Accruals Ratio (Sloan)
-6.8%
Net Debt
$-621M
Net Debt / EBITDA
-172.53
Cash Coverage
2.11
Capex Coverage
Tangible Common Equity
$578M
TCE / Total Assets
7.6%
Cash ROIC
115.8%
Capex / D&A
Total Payout Ratio
56.9%
Asset Growth vs Revenue Growth
83.0%
Revenue 5Y CAGR
28.4%
EPS 5Y CAGR
5.4%
FCF 5Y CAGR
24.7%
EBITDA 5Y CAGR
24.6%
Book Value 5Y CAGR
51.4%
Stock Price (FY-end)
$67
Market Cap
$1.28B
P/E Ratio
10.51
P/S Ratio
0.65
P/B Ratio
2.11
P/TB Ratio
2.22
P/OCF Ratio
2.01
P/FCF Ratio
2.01
Enterprise Value
$663M
EV / EBITDA
184.08
EV / Sales
0.34
EV / FCF
1.04
FCF Yield
49.7%
Shareholder Yield
5.1%
Buyback Yield
5.4%
Capex Yield
Graham Number
$67
Shares Variation (YoY)
2.0%
Beta (5Y)
1.68
Cost of Equity
12.9%
52W High
$76
52W Low
$43
Trailing Return 1Y
17.5%
Trailing Return 5Y
153.5%

Earnings Forecasts

Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).

Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.

EPS — Consensus vs Actual

Revenue — Consensus vs Actual

Stock Price on Earnings Dates

ATLANTICUS HOLDINGS CORPORATION — Effective Tax Rate ReconciliationNEW

Bridges from the federal statutory rate (21% post-TCJA) to the effective tax rate via the issuer's tax-note reconciliation lines. Sourced from EffectiveIncomeTaxRateReconciliation* flat CompanyFacts concepts. Conditional lines (R&D credits, FDII, SBC, valuation allowance, etc.) only render when the issuer discloses them. Persistent divergence between accrual tax expense and cash taxes paid is a leading signal for deferred-tax buildup.

Effective Rate Trend

Reconciliation LineFY2020FY2021FY2022FY2023FY2024FY2025
Federal Statutory Rate21.00%21.00%21.00%21.00%21.00%
State & Local Income Taxes-0.10%1.60%2.70%2.40%3.00%3.50%
Foreign Rate Differential-0.20%-0.10%-0.20%-0.20%-0.20%-0.20%
Other Adjustments0.20%-0.60%-0.10%-0.40%0.40%0.10%
Valuation Allowance Change
Tax Law Change
Effective Tax Rate17.90%19.00%9.80%20.60%20.40%24.20%

Cash vs Accrual

ItemFY2020FY2021FY2022FY2023FY2024FY2025
Income Tax Expense (Accrual)$20.5M$41.8M$14.7M$26.6M$28.5M$39.1M
Income Taxes Paid (Cash)$327.0K$19.9M$4.2M$1.5M$229.0K$1.0M

ATLANTICUS HOLDINGS CORPORATION — M&A AcquisitionsNEW

Per-deal acquisition disclosures sourced from us-gaap:BusinessAcquisitionAxis dimensional XBRL. Each card surfaces the deal's purchase-price allocation (goodwill vs intangibles vs liabilities), contingent consideration (unpaid earn-outs), and pro-forma combined-entity numbers. Probability-of-Success (PoS) factor on biotech targets is the ASC 805 contingent-consideration valuation — higher = closer to commercialization, higher implied target value.

Mercury Financial Llc

Total Consideration

$166.5M